Researchers from Baylor College of Medicine and Texas Children's Hospital now provide evidence that epileptic spasms originate from the pyramidal cells in the deep layers of the neocortex.
Genetics, Pediatric Epilepsy, SUDEP
A round-up of epilepsy research news from the past month.
A national COVID-19 lockdown may have led to worse seizure control and health status in some people with epilepsy. Easy access to antiepileptic drugs and their appropriate use may be especially useful to prevent seizure exacerbation during strict COVID-19 restrictions.
Emotional and behavioral problems are common among children with epilepsy. Common symptom clusters include attention problems, aggressive behavior, social problems, and withdrawal/depression. There is need to screen for these problems for early identification and management in order to improve outcomes.
A new study shows how 'tipping points' in the brain, responsible for diseases including epilepsy, can be better predicted by accounting for branches in networks of neurons.
Genetics, Pediatric Epilepsy
Chromosome 1q41-q42 deletion syndrome is a rare cause of intellectual disability, seizures, dysmorphology, and multiple anomalies.
While the importance of managing depression and anxiety in patients with epilepsy is being recognized, there are ongoing barriers to effective mental health care. Key future directions include the need for updated protocols in this area and the integration of mental health professionals within epilepsy settings.
This app, now validated by experts, provides an objective, reproducible method for selecting antiseizure medication that accounts for relevant clinical features.
There is a slightly increased risk of hospital admission and death from COVID-19 in people with epilepsy, according to a new study in the British Medical Journal (BMJ).
